The standard therapy that we offer is:
- Pegylated interferon (an injection of a protein to stimulate the immune system to attack virus cells. This involves you making a small injection yourself once a week. You can be shown how to do this by a Specialist Hepatitis C Nurse.
- Ribavirin: antiviral tablets that are active against the spread of hepatitis C in the body.
This treatment can clear the hepatitis C virus from the body in 80-90 % of cases if treatment is started soon after exposure, and if the infection is caused by genotypes 2 or 3 of the hepatitis C virus. Find out more about the genotypes of hepatitis C.
If the infection is due to any of the other 4 genotypes, or if treatment is started once the infection has become chronic, clearance of the virus is greatly reduced. New hope for hepatitis C patients
In 2011, 2 new drugs were approved to treat people with hepatitis C. This is a significant advance, as these are the first new treatments to be approved in the USA or Europe for 20 years.
- Victrelis (Boceprevir®) available in the UK since July 2011when it was passed for approval by the European Medicines Agency (EMA).
- Telaprevir (Incivek®) was also approved by the EMA in the late summer of 2011 and can now be added to the standard therapy for patients with hepatitis C in our outpatient clinic.
Both these drugs have been shown to significantly increase the chances of clearing the virus in some cases of Hepatitis C infection. Side effects of hepatitis C treatment
Hepatitis C infection can cause no symptoms but treatment with interferon can produce several side effects:
- Tiredness and irritability
- Mood swings
- Concentration difficulties
- An itchy rash
- Mild anaemia
- Lack of interest in food
- Poor sleep.